{"DataElement":{"publicId":"3078764","version":"1","preferredName":"Relapse Tumor Relapse Histologic Subtype Type","preferredDefinition":"Text term to represent the predominant histologic subtype in a relapsed tumor.","longName":"3076552v1.0:3078429v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3076552","version":"1","preferredName":"Relapse Tumor Dominant Histologic Subtype","preferredDefinition":"The return of signs and symptoms of cancer after a period of improvement._Occurring first in time or sequence; original; of greatest rank or importance or value._Occurring first in time or sequence; original; of greatest rank or importance or value._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._Exercising influence or control._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","longName":"3076550v1.0:3076537v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3076550","version":"1","preferredName":"Relapse Neoplasm","preferredDefinition":"The return of signs and symptoms of cancer after a period of improvement.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C18265:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relapse","conceptCode":"C18265","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8527E75C-F889-D579-E040-BB89AD434D8F","latestVersionIndicator":"Yes","beginDate":"2010-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-26","modifiedBy":"ONEDATA","dateModified":"2010-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3076537","version":"1","preferredName":"Dominant Histologic Subtype","preferredDefinition":"Exercising influence or control.:Of or relating to histology.:Subtype; a group forming a type within a larger type.","longName":"C25487:C25526:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dominant","conceptCode":"C25487","definition":"Exercising influence or control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85277787-620F-4197-E040-BB89AD432C40","latestVersionIndicator":"Yes","beginDate":"2010-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-26","modifiedBy":"ONEDATA","dateModified":"2010-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8527E75C-F897-D579-E040-BB89AD434D8F","latestVersionIndicator":"Yes","beginDate":"2010-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3078429","version":"1","preferredName":"Wilms Tumor Histologic Relapse Subtype Type","preferredDefinition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._The return of signs and symptoms of cancer after a period of improvement._Subtype; a group forming a type within a larger type._Type; a subdivision of a particular kind of thing.","longName":"3078429v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Low Risk","valueDescription":"Low Risk","ValueMeaning":{"publicId":"2957593","version":"1","preferredName":"Low Risk","longName":"2957593","preferredDefinition":"A minimum level or position or degree; less than normal in degree or intensity or amount.: Risk is the potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable. (from WIkipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low","conceptCode":"C54722","definition":"A minimum level or position or degree; less than normal in degree, intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7731E68C-E025-7118-E040-BB89AD43735A","latestVersionIndicator":"Yes","beginDate":"2009-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8538D940-324B-8FB5-E040-BB89AD432950","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","deletedIndicator":"No"},{"value":"Intermediate Risk","valueDescription":"Intermediate Risk","ValueMeaning":{"publicId":"3078430","version":"1","preferredName":"Intermediate Risk","longName":"3078430","preferredDefinition":"Intermediate Risk","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8538D940-3256-8FB5-E040-BB89AD432950","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8538D940-326F-8FB5-E040-BB89AD432950","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","deletedIndicator":"No"},{"value":"High Risk","valueDescription":"High Risk","ValueMeaning":{"publicId":"3078431","version":"1","preferredName":"High Risk","longName":"3078431","preferredDefinition":"High Risk","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8538D940-3279-8FB5-E040-BB89AD432950","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8538D940-3292-8FB5-E040-BB89AD432950","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","deletedIndicator":"No"},{"value":"Anaplasia","valueDescription":"Anaplasia","ValueMeaning":{"publicId":"3078432","version":"1","preferredName":"Anaplasia","longName":"3078432","preferredDefinition":"Anaplasia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8538D940-329C-8FB5-E040-BB89AD432950","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8538D940-32B5-8FB5-E040-BB89AD432950","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","deletedIndicator":"No"},{"value":"None","valueDescription":"No relapse","ValueMeaning":{"publicId":"3201497","version":"1","preferredName":"No relapse","longName":"3201497","preferredDefinition":"No relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2284C5-1633-FD97-E040-BB89AD4373F9","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E2284C5-164C-FD97-E040-BB89AD4373F9","beginDate":"2011-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not available","ValueMeaning":{"publicId":"3073069","version":"1","preferredName":"Not available","longName":"3073069","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84C32C62-B161-768A-E040-BB89AD437163","latestVersionIndicator":"Yes","beginDate":"2010-04-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-04-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E2284C5-1656-FD97-E040-BB89AD4373F9","beginDate":"2011-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-03-10","modifiedBy":"ONEDATA","dateModified":"2011-03-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3078428","version":"1","preferredName":"Wilms Tumor Histologic Relapse Subtype Type","preferredDefinition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.:Of or relating to histology.:The return of signs and symptoms of cancer after a period of improvement.:Subtype; a group forming a type within a larger type.:Type; a subdivision of a particular kind of thing.","longName":"C3267:C25526:C18265:C25696:C25","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wilms Tumor","conceptCode":"C3267","definition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Relapse","conceptCode":"C18265","definition":"The return of signs and symptoms of cancer after a period of improvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8538D940-321B-8FB5-E040-BB89AD432950","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"ONEDATA","dateModified":"2010-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8538D940-322C-8FB5-E040-BB89AD432950","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"COOPERM","dateModified":"2014-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5650570","version":"1","longName":"TARGET","context":"OCG","ClassificationSchemeItems":[{"publicId":"5650573","version":"1","longName":"Kidney Tumors","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Predominant histologic subtyp","type":"Preferred Question Text","description":"Predominant histologic subtype of relapse tumor","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"853C25A7-CEC0-0B5D-E040-BB89AD433303","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"COOPERM","dateModified":"2017-02-02","changeDescription":"Released per approval by T.Davidsen. mc 6/21/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}